Literature DB >> 7608045

Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up.

M Strober1, S Schmidt-Lackner, R Freeman, S Bower, C Lampert, M DeAntonio.   

Abstract

OBJECTIVE: This study was a 5-year naturalistic prospective follow-up of 54 consecutive admissions of adolescents to a university inpatient service with a diagnosis of bipolar I affective illness.
METHOD: Subjects received structured clinical evaluations every 6 months after entry to establish time to recovery and subsequent relapse. Regression models were used to identify predictors of differential course.
RESULTS: Rate of recovery varied by polarity of episode at time of entry, with quick recovery observed in subjects with pure mania or mixed states, and a protracted index episode in subjects with pure depression. Multiple relapses were most often seen in subjects with mixed or cycling episodes at intake.
CONCLUSIONS: Polarity of illness may have utility in identifying bipolar adolescents with a more recurrent illness. Comparison with adult data suggests that recurrence risks may vary as a function of age at onset or stage of the disease process.

Entities:  

Mesh:

Year:  1995        PMID: 7608045     DOI: 10.1097/00004583-199506000-00012

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  58 in total

1.  Mood disorders in children and adolescents: coming of age.

Authors:  M K Nixon
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

2.  Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.

Authors:  Robert L Findling; Sanjeev Pathak; Willie R Earley; Sherry Liu; Melissa DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

3.  Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.

Authors:  Melissa M Jenkins; Eric A Youngstrom; Jennifer Kogos Youngstrom; Norah C Feeny; Robert L Findling
Journal:  Psychol Assess       Date:  2011-10-17

Review 4.  Suicide risk factors in children and adolescents with bipolar disorder.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

5.  Clinical correlates of suicidality and self-injurious behaviour among Canadian adolescents with bipolar disorder.

Authors:  Diana Khoubaeva; Mikaela Dimick; Vanessa H Timmins; Lisa M Fiksenbaum; Rachel H B Mitchell; Ayal Schaffer; Mark Sinyor; Benjamin I Goldstein
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-05-24       Impact factor: 4.785

6.  Phenomenology, longitudinal course, and outcome of children and adolescents with bipolar spectrum disorders.

Authors:  Regina Sala; David Axelson; Boris Birmaher
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

Review 7.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

Review 8.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

9.  Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.

Authors:  Timothy E Wilens; Joseph Biederman; MaryKate Martelon; Courtney Zulauf; Jesse P Anderson; Nicholas W Carrellas; Amy Yule; Janet Wozniak; Ronna Fried; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

10.  Substance use disorders among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Michael A Strober; Boris Birmaher; David A Axelson; Christianne Esposito-Smythers; Tina R Goldstein; Henrietta Leonard; Jeffrey Hunt; Mary Kay Gill; Satish Iyengar; Colleen Grimm; Mei Yang; Neal D Ryan; Martin B Keller
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.